• A deficiency in G6PT impairs neutrophil energy homeostasis characterized by reduced intracellular levels of G6P, ATP, lactate, and NADPH • Impaired energy homeostasis and activation of the HIF-1α/PPAR-γ pathway underlie neutrophil dysfunction in GSD-Ib
Introduction
Neutrophils constitutively express PPAR-γ, 30 and ligand-activation of PPAR-γ inhibits their chemotactic responses. 30 Moreover, nitric oxide-elicited PPAR-γ activation down regulates the expression of NADPH oxidase subunit, p47 phox , leading to inhibition of respiratory burst that plays critical roles in antibacterial host defenses.
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In this report, we examine energy homeostasis and activation of the HIF-1α/PPAR-γ pathway in neutrophils of GSD-Ib patients. We show that G6PT-deficient neutrophils do exhibit impaired energy homeostasis along with reduced expression and activation of p47 phox , compared to neutrophils from healthy subjects. Moreover, the HIF-1α/PPAR-γ pathway is activated in G6PT-deficient neutrophils, leading to impairment in neutrophil respiratory burst, chemotaxis, and calcium mobilization activities. Together these findings show that the G6PT-mediated G6P/glucose cycling is essential for neutrophil homeostasis and G6P metabolism and a deficiency leads to impaired energy homeostasis and activation of the HIF-1α/PPAR-γ pathway which underlie, at least in part, neutrophil dysfunction in GSD-Ib.
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Methods

Subjects
Fifteen GSD-Ib patients (aged 5 to 40 years), 4 GSD-Ia patients (aged 18 to 43 years) and 13 health donors (HDs) (aged 17 to 42 years) were included in the study. All patients were diagnosed by standard clinical biochemical methods and confirmed by gene mutation analysis. All subjects were treated with daily granulocyte colony-stimulating factor (G-CSF) therapy at the time of the studies with doses ranging 1.0 -4.8 µg/kg/day. Samples were obtained during research admissions when subjects were in good health. The study was approved by the Clinical Investigation Committee at the University of Florida, College of Medicine and at the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH). Informed written consent and assent when appropriate was obtained from all subjects participating in the study. The study was conducted in accordance with the Declaration of Helsinki.
GSD-Ib is an ultra-rare orphan disease with an incidence of 1:700,000 1, 2 and access to patients is limited. While the primary disease phenotypes are explained by the SLC37A4 mutations, patient to patient variability is expected as a result of the low number of patients available for the study and their background genetic variation.
Flow cytometry analysis
Heparinized human peripheral blood cells were erythrocyte-depleted and fixed in Lysis/Fix buffer (BD Biosciences). The resulting leukocytes were stained with a FITC-conjugated mouse monoclonal CD66b antibody (BD Pharmingen) and a PE-conjugated CD16 antibody neutrophils were analyzed by flow cytometry using a Guava EasyCyte Mini System (Millipore).
Isolation of non-apoptotic human blood neutrophils and analysis of neutrophil function
Heparinized human peripheral blood cells were erythrocyte-depleted with Ack lysing buffer (Quality Biologicals). The resulting leukocytes were incubated with annexin V Microbeads
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From (Miltenyi Biotec) to deplete apoptotic cells as described previously. 10 Neutrophils used for all assays were isolated from annexin V-depleted blood leukocytes using the CD66abce MicroBead Kit (Miltenyi Biotec). The viability of annexin-V-depleted neutrophils was assessed using the Guava viacount reagent (Millipore) that contains 7-amino-actinomyocin D (7-AAD). The viable neutrophils were annexin V (-) and 7-AAD (-). The purity and nuclear morphology of isolated neutrophils were examined on Hema-3 (Fisher Scientific) stained cytospin slides. Neutrophil respiratory burst, chemotaxis, and calcium flux were determined as described previously.
8-10
Immunofluorescence microscopy Neutrophils were plated onto glass slides by cytospin, fixed in paraformaldehyde, and incubated with Image-iFX signal enhancer (Invitrogen) as described previously. 10 To examine translocation of GLUT1 and p47 phox to the plasma membrane, fixed neutrophils were incubated with rabbit polyclonal antibodies against GLUT1 (Santa Cruz Biotechnology) and pan Cadherin To detect HIF-1α, fixed neutrophils were permeabilized in 0.3% Triton X-100 and incubated with a mouse monoclonal antibody against HIF-1α (Novus biologicals). Then, neutrophils were incubated with an anti-mouse IgG antibody, conjugated with Alexa Fluor 488, mounted with anti-fade medium containing DAPI, and visualized using a EVOS fl inverted microscope equipped with 20×/0.4 and 40×/0.65 NA objectives (Advanced Microscopy Group). Images were acquired using AMG acquisition software.
The integrated fluorescence intensity of each stained cell and the integrated fluorescence intensity of protein translocated to the plasma membrane in the merged cells were quantified
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Quantitative real-time RT-PCR, Western blot, and cytokine analyses
The mRNA expression was quantified by real-time RT-PCR in an Applied Biosystems 7300
Real-Time PCR System as described previously. 10 The TaqMan Western blot analysis was performed as described previously. 10, 11 Mouse monoclonals used were: gp91 phox (Biolegend), p47 phox (BD Biosciences), and HIF-1α (Novus biologicals).
Rabbit polyclonals used were: HK3, GLUT1, p22 phox , PPAR-γ (Santa Cruz Biotechnology) and Hsp90 (Cell Signaling). Protein expression was quantified by densitometry as described previously. 10, 11 Serum IL-4 was quantified using Quantikine ELISA kits (R&D Systems).
Glucose uptake, G6P, lactate, ATP, and NADPH determination
Glucose uptake and determination of intracellular levels of G6P, lactate, and ATP were as described previously. 10 To measure intracellular NADPH, 10 5 cells were lysed in 200 μ L of NADP/NADPH extraction buffer as described in the instruction manual (BioVision). To decompose NADP, the extracted NADP/NADPH solution was incubated at 60 °C for 30 min, followed by cooling on ice. Total NADP/NADPH and NADPH were measured by incubation with NADP cycling enzyme mix (BioVision) for 5 min at room temperature to convert NADP to NADPH and the optical density at 450 nm was determined in a spectrophotometer. µM GW9662 or 0.02% DMSO. HD neutrophils incubated for 2 hours at 37 ºC under normoxia with 0.02% DMSO were used as controls for groups 3 and 4 neutrophils. Group-5 neutrophils were pretreated for 1 hour at 37 ºC with 2 µM 2-ME2 or 0.02% DMSO under normoxia, followed by incubation for 2 hours at 37 ºC under hypoxia. HD neutrophils incubated at 37 ºC for 3 hours in 0.02% DMSO under normoxia were used as controls. Chemotaxis and calcium mobilization in response to 10 -7 M fMLP and respiratory burst in response to 200 ng/ml of PMA were determined as described previously. [8] [9] [10] The effects of GW9662 on the function of G6PT-deficient neutrophils suspended in the above medium were also examined. For chemotaxis analysis, G6PT-deficient neutrophils in response to fMLP was conducted in the presence of either 20 µM GW9662 or 0.02% DMSO for 1 hour at 37 ºC. For calcium mobilization and respiratory burst analyses, [8] [9] [10] G6PT-deficient neutrophils were treated with either 20 µM GW9662 or 0.02% DMSO for 1 hour at 37 ºC.
Statistical analysis
The unpaired t test was performed using the GraphPad Prism Program, version 4 (GraphPad Software). Values were considered statistically significant at P less than 0.05.
Results
The dysfunctional G6PT-deficient neutrophils vary greatly in their maturation states
Fifteen human GSD-Ib patients on daily low dose G-CSF therapy were included in this study (Table 1) . Thirteen normal HDs and 4 GSD-Ia patients (Table 1) were included as controls. The levels of total (CD66b + ) and immature (CD66b + /CD16 lo/-) neutrophils in the fixed, erythrocytedepleted blood leukocytes were analyzed by flow cytometry ( Figure 1A) . Total blood neutrophil counts in GSD-Ib patients varied greatly with 5 patients exhibiting mild neutropenia (bold in Table 1 ). The immature neutrophils in HDs (n = 13) and GSD-Ia patients (n = 4) averaged 0.4-18% of total blood leukocytes. Among the 15 GSD-Ib patients, P13, P14 and P15 had normal levels (4.4-17%), 6 had intermediate levels (33-58%), and 6 had high levels (64-92%) of immature neutrophils (Table 1 ). The maturation states of neutrophils from GSD-Ib patients were confirmed by nuclear morphological analysis of the Hema-3 stained cytospin slides ( Figure 1B ).
Notably, no correlation existed between the age of the patients and the maturation states of their neutrophils.
Peripheral blood neutrophils of GSD-Ib patients exhibit enhanced apoptosis ( Figure   1C ). 9, 12 To measure neutrophil function accurately, we depleted apoptotic cells from blood leukocytes by annexin V MicroBead Kit, followed by using the CD66abce MicroBead Kit to isolate neutrophils from annexin V-depleted blood leukocytes. Annexin V-depleted neutrophils from HDs and GSD-Ib patients were of similar viability ( Figure 1C ) and were used in the experiments described below.
In neutrophils from HDs or GSD-Ia patients, superoxide production was markedly increased by exposure to PMA while in non-apoptotic neutrophils from GSD-Ib patients, the PMA-stimulated superoxide production was reduced, regardless of the maturation states of the patients' neutrophils ( Figure 1D ). Neutrophils from HDs or GSD-Ia patients exhibited a greater chemotactic response to fMLP than neutrophils from GSD-Ib patients ( Figure 1E ). The neutrophil chemotactic responses of 5 GSD-Ib patients, harboring 4-58% of immature neutrophils, varied only slightly ( Figure 1E ), again suggesting the minor role of the maturation state played in neutrophil chemotaxis. Similarly, calcium mobilization in response to fMLP was impaired in G6PT-deficient neutrophils relative to control neutrophils while GSD-Ia neutrophils exhibited normal calcium mobilization activity ( Figure 1F ).
Reduced glucose uptake and decreased intracellular G6P, lactate, and ATP in G6PT-deficient neutrophils
In neutrophils, glucose is mainly supplied from the blood via GLUT1 facilitated uptake.
16,34
Within neutrophils, glucose is phosphorylated to G6P by HK. 17,18 Therefore, glucose uptake can be controlled by glucose transport and phosphorylation. Annexin V-depleted neutrophils from
HDs took up 2-DG at a rate 1.5-fold greater than neutrophils from GSD-Ib patients ( Figure 2A ).
The GLUT1 mRNA levels in G6PT-deficient neutrophils were significantly higher than those in HD neutrophils ( Figure 2B ). However, Western blots showed that GLUT1 protein levels in GSD-Ib and HD neutrophils were similar ( Figure 2C and 2D). Confocal microscopic analysis confirmed that membrane associated GLUT1 was similar between HD and GSD-Ib neutrophils ( Figure 2E ). The expression of HK1 mRNA is downregulated, HK2 is unchanged, but the expression of HK3, the major HK isozyme in neutrophils, 35, 36 is increased 4-fold in G6PT-deficient neutrophils compared to controls ( Figure 2F ). Western blots confirmed a 4.3-fold increase in HK3 protein levels in G6PT-deficient neutrophils ( Figure 2C and 2D).
We have previously shown that a disruption of the G6PT/G6Pase-β-mediated G6P/glucose cycling in G6Pase-β-deficient neutrophils results in impaired energy homeostasis, characterized by reduced intracellular levels of G6P, ATP, and lactate. 10 We now show that G6PT-deficient neutrophils exhibited a similar impairment. The intracellular levels of G6P, lactate, and ATP in neutrophils from GSD-Ib patients (n = 12) were 71.9%, 74.4%, and 68.4%, respectively of the levels in the control subjects (n = 13) ( Figure 2G ). In summary, G6PT-deficient neutrophils exhibited impaired glucose uptake and harbored reduced intracellular levels of G6P, lactate, and ATP compared to HD neutrophils.
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NADPH oxidase is a multicomponent enzyme system composed of two transmembrane proteins, gp91 phox and p22 phox , and several cytosolic proteins. 37, 38 For activation of NADPH oxidase activity, the cytosolic subunit, p47 phox must translocate from the cytoplasm to the plasma membrane. 40 In G6PT-deficient neutrophils, gp91 phox mRNA levels were increased and p22 phox mRNA levels were unchanged compared to HD neutrophils ( Figure 3B ). Hayee et al. 41 have shown that gp91 phox is hypo-glycosylated in neutrophils of GSD-Ib patients but the abnormal glycosylation does not interfere with electron transport or assembly of the oxidase complex in a cell-free system. Western blots showed that levels of both glycosylated and hypoglycosylated gp91 phox existed in HD and GSD-Ib neutrophils and their levels varied greatly ( Figure 3C ). In agreement with Hayee et al, 41 levels of glycosylated gp91 phox in G6PT-deficient neutrophils were significantly lower than that in HD neutrophils ( Figure 3D ). Western blots confirmed that neutrophil p22 phox protein levels were similar between HDs and GSD-Ib patients ( Figure 3D ).
Quantitative real-time RT-PCR ( Figure 3B ) and Western blots ( Figure 3C and 3D) showed that the expression of p47 phox was decreased in G6PT-deficient neutrophils, compared to the controls. Confocal microscopic analysis showed that the amounts of p47 phox translocated to the plasma membrane were markedly decreased in G6PT-deficient neutrophils ( Figure 3E ).
Therefore, the impaired respiratory burst inherent of G6PT-deficient neutrophils is associated with impairment of both the expression of p47 phox and the activation of NADPH oxidase.
Activation of the HIF-1α/PPAR-γ pathway in G6PT-deficient neutrophils
The regulation of HIF-1α occurs primarily at the level of protein stabilization. 22 In addition to the hypoxia environment, HIF-1α can be activated by various stimuli, including ROS 22,29 and
Hsp90. 42, 43 Studies have shown that G6PT-deficient neutrophils exhibit elevated levels of ROS. 9, 12 We now show that levels of Hsp90 transcript and protein ( Figure 4A and 4B) were markedly increased in annexin V-depleted G6PT-deficient neutrophils, compared to the controls.
The expression of neutrophil HIF-1α mRNA was similar between GSD-Ib patients and HDs ( Figure 4A ). In contrast, HIF-1α protein levels in G6PT-deficient neutrophils were 6.2-fold higher than the levels in HD neutrophils ( Figure 4A and 4B). Immunofluorescence analysis confirmed the increase in the HIF-1α protein in G6PT-deficient neutrophils ( Figure 4C ).
HIF-1α is an activator of PPAR-γ. 27 The levels of PPAR-γ mRNA ( Figure 4D GSD-Ib patients included in this study are under G-CSF therapy. We therefore examined the expression of PPAR-γ in HD neutrophils after culturing in vitro in medium containing G-CSF. Figure 4E shows that G-CSF has little effect on PPAR-γ expression in HD neutrophils upon short exposure (0 to 4 hour), while at longer exposures (12 hour) there may be decreased expression.
To further test the hypothesis that dysfunctional chemotaxis, calcium mobilization, and respiratory burst activities in neutrophils of GSD-Ib patients are mediated by PPAR-γ, we examined the effects of PPAR-γ agonist rosiglitazone and/or antagonist GW9662 on the function of freshly isolated HD neutrophils. The chemotaxis and calcium mobilization in response to fMLP and the PMA-stimulated superoxide production in HD neutrophils were markedly inhibited by rosiglitazone but reversed upon addition of GW9662 ( Figure 4F ). Importantly, in G6PT-deficient neutrophils, fMLP-mediated chemotaxis and calcium mobilization, as well as the PMA-
superoxide production, were markedly improved by the addition of PPAR-γ antagonist GW9662 ( Figure 4G ).
To demonstrate that inhibition of neutrophil function by PPAR-γ is mediated via HIF-1α signaling, neutrophil function was examined in HD neutrophils that had increased HIF-1α and PPAR-γ protein levels induced by exposure to either hypoxic conditions ( Figure 5A ) or the hypoxia mimetic CoCl 2 33 ( Figure 5B ). Neutrophil chemotaxis, calcium mobilization, and superoxide production were all inhibited by hypoxia ( Figure 5A ) or CoCl 2 ( Figure 5B ). These functional impairments were reversed upon the addition of a PPAR-γ antagonist GW9662 that also decreased the protein levels of HIF-1α and PPAR-γ ( Figure 5A and 5B). HIF-1α is an activator of PPAR-γ 27 but activation of PPAR-γ also increases the expression of HIF-1α, 44 suggesting that the expression of HIF-1α and PPAR-γ are co-dependent.
To further demonstrate that activation of the HIF-1α/PPAR-γ pathway impairs neutrophil function, HD neutrophils were exposed to 2-ME2, a pharmacologic inhibitor of HIF-1α activity. 32 As in the previous experiment, the hypoxia-mediated inhibition of neutrophil calcium mobilization and superoxide production was associated with increased levels of HIF-1α and PPAR-γ ( Figure 5C ) and the functional impairment was reversed upon the addition of 2-ME2 that also reduced the levels of both proteins ( Figure 5C ). Studies have shown that microtubules control neutrophil motility and disruption of microtubules impairs neutrophil chemotaxis. 45 The 2-ME2 disrupts microtubules, an action required for HIF-1α downregulation. 32 Consequently, the hypoxia-mediated inhibition of neutrophil chemotaxis was not reversed by 2-ME2 treatment ( Figure 5C ).
For
Discussion
The G6PT and G6Pase-β activities are known to be functionally co-dependent.
1,2 One role of the G6PT/G6Pase-β complex is to maintain intracellular glucose homeostasis in neutrophils [6] [7] [8] [9] [10] and macrophages 11 during periods of increased energy demand. Recent studies showed that the loss of the G6PT/G6Pase-β activity in GSD-Ib 9,12 and G6Pase-β-deficiency 6, 8, 10 leads to increased neutrophil ER stress, oxidative stress and apoptosis, leading to neutropenia ( Figure 6 ). Beyond neutropenia, GSD-Ib and G6Pase-β-deficient patients also manifest neutrophil dysfunction characterized by impairments in respiratory burst, chemotaxis, and calcium mobilization. 1,2 The underlying mechanism of neutrophil dysfunction is not understood well. There are three primary pathways competing for intracellular G6P/glucose in neutrophils, namely, glycolysis, the HMS, and the G6PT/G6Pase-β-mediated cycling of G6P/glucose between the cytoplasm and ER 10 ( Figure 6 ). We have shown that disruption of G6P/glucose cycling in G6Pase-β deficiency leads to impaired neutrophil energy homeostasis, which underlies, at least in part, neutrophil dysfunction seen in this disorder. 10 We hypothesized that G6PT-deficient neutrophils would also exhibit impaired energy homeostasis. In this study, we show that neutrophils from GSD-Ib patients exhibit reduced glucose uptake and decreased intracellular levels of G6P, ATP, lactate, and NADPH ( Figure 6 ).
One reasonable explanation of the cytoplasmic G6P/glucose deficiency in G6PT-deficient neutrophils is that ER cycling and blood glucose uptake are co-regulated by HK3. Both G6PT-and G6Pase-β-deficient neutrophils exhibit reduced glucose uptake and decreased intracellular levels of G6P, ATP, and lactate. While GLUT1 levels were decreased in G6Pase-β-deficient neutrophils, 10 GLUT1 expression in G6PT-deficient neutrophils were similar to that of HD neutrophils, suggesting mechanisms beyond transporter availability are involved. Glucose uptake can also be controlled by glucose phosphorylation. The major HK isozyme in neutrophils is HK3 36 that also plays a role of protecting cells from oxidant-induced cell death. 46 The expression of HK3 is upregulated by HIF-1α 46 and consistent with this we observed that both HK3 mRNA and protein are increased 4-fold in G6PT-deficient neutrophils. In ER cycling, G6P
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From enters the ER via G6PT where it accumulates until it is hydrolyzed by G6Pase-β to glucose. The ER regenerated glucose then diffuses across the ER membrane into the cytoplasm where it can be re-phosphorylated by HK to G6P and re-enter glycolysis or HMS pathway; or be recycled again via the ER. In neutrophils of normal subjects, one role of HK3 is to maintain a glucose concentration gradient across the ER membrane necessary for glucose to diffuse from the ER into the cytoplasm. In G6PT-deficient neutrophils, ER cycling is blocked and upregulation of HK3 fails to increase the glucose gradient across the ER to rectify the cytoplasmic deficiency.
Since an increase in HK activity will also increase the glucose gradient across the cell membrane, increasing the rate of GLUT facilitated diffusion, this raises the possibility that ER cycling also regulates glucose uptake from the plasma membrane mediated by GLUT. Studies have shown that GLUT uptake of blood glucose also increases when cytoplasmic levels of lactate and ATP increase. 47, 48 In G6PT-deficient neutrophils, with lower than normal levels of ATP and lactate, this mechanism of increasing glucose uptake is also not available, exacerbating the low cytoplasmic G6P/glucose levels caused by the absence of ER cycling.
In addition to impaired energy homeostasis, we provide evidence that activation of the HIF-1α/PPAR-γ pathway leads to impairments in respiratory burst, chemotaxis, and calcium mobilization in G6PT-deficient neutrophils ( Figure 6 ). GSD-Ib patients included in this study were under G-CSF therapy which improves neutrophil counts and decreases the number and severity of bacterial infections. 14,49 Therefore one concern is that the GCSF therapy may impact the findings from the patient neutrophils to the extent that GCSF by itself might be activating the HIF-1α/PPAR-γ pathway. We now showed that PPAR-γ expression is not affected by G-CSF treatment in HD neutrophils. While we cannot demonstrate this in G6PT-deficient neutrophils without interfering with patients' standard of care, it is reasonable to suggest that G-CSF does not drive PPAR-γ expression. Instead the HIF-1α/PPAR-γ pathway in G6PT-deficient neutrophils is stimulated in response to the increase in ROS 9, 12 and Hsp90 (this study), which are inducers of HIF-1α via protein stabilization. 29,42,43 HIF-1α is an upstream activator of PPAR-γ. 27 Studies have shown that in monocytes/macrophages, PPAR-γ activation downregulates the 30 We show that the expression of both HIF-1α and PPAR-γ in G6PT-deficient neutrophils is also markedly stimulated, compared to HD neutrophils, but that is independent of IL-4. Moreover, the expression and membrane translocation of p47 phox is reduced in G6PT-deficient neutrophils. We further show that freshly isolated human neutrophils exposed to a PPAR-γ agonist have reduced respiratory burst, chemotaxis, and calcium mobilization activities but these activities are restored by the addition of a countering PPAR-γ antagonist. Moreover, exposing G6PT-deficient neutrophils to a PPAR-γ antagonist improves their function.
HIF-1α regulates the expression of multiple genes but the function of this transcription factor is complex, and not fully understood. For instance, myeloid lineage-specific knockout mice have reduced neutrophil survival, 24 decreased bactericidal activity, 25 but normal neutrophil endothelial transcytosis or oxidative burst function. 25 However, under hypoxia, a condition that increases HIF-1α protein levels, neutrophils are still negatively impacted with impaired respiratory burst activity. 26 We now show that in both HD and G6PT-deficient neutrophils, activation of PPAR-γ, a nuclear receptor that acts downstream of HIF-1α, 27 leading to neutrophil dysfunction characterized by impairments in respiratory burst, chemotaxis, and calcium mobilization activities. We further provide evidence demonstrating that inhibition of neutrophil function by PPAR-γ is mediated via HIF-1α signaling. In HD neutrophils, the increase in HIF-1α protein levels either by hypoxia or the hypoxia mimetic CoCl 2 33 reduce respiratory burst, chemotaxis, and calcium mobilization activities but these activities are restored upon the addition of a PPAR-γ antagonist. Furthermore, downregulation of HIF-1α activity by 2-ME2 32 reverses the hypoxia-mediated inhibition of neutrophil calcium mobilization and respiratory burst activities.
In conclusion, we have shown that G6PT expression is important for neutrophil energy homeostasis and that the G6PT defect leads to reduced glucose uptake and decreased intracellular levels of G6P, ATP, lactate, and NADPH. The disruption in neutrophil energy transported into the cytoplasm via GLUT1 is metabolized by HK to G6P which participates in 3 major pathways: glycolysis, the HMS, and ER cycling. In cycling, G6P enters the ER via G6PT where it can accumulate until it is hydrolyzed to glucose by G6Pase-β and transported back into the cytoplasm. By limiting the cytoplasmic glucose/G6P availability, cycling regulates the other two cytoplasmic pathways for G6P metabolism. Disruption of ER cycling in G6PT-deficient neutrophils results in reduced glucose uptake, impaired energy homeostasis and functionality. The underlying cause of neutropenia in GSD-Ib is enhanced neutrophil ER stress and oxidative stress. 10 The increases in Hsp90
and ROS in G6PT-deficient neutrophils stabilize HIF-1α, an upstream activator of PPAR-γ. The increase in PPAR-γ downregulates neutrophil respiratory burst, chemotaxis and calcium mobilization activities. GLUT1, responsible for the transport of glucose in and out of the cell, is shown embedded in the plasma membrane. The G6PT, responsible for the transport of G6P into the ER and G6Pase-β, responsible for hydrolyzing G6P to glucose and phosphate, are shown embedded in the ER membrane.
Thick arrows indicate the changes caused by a defect in G6PT activity.
